| Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 126.06 mm | 126.06 mm | 126.06 mm | 126.06 mm | 126.06 mm | 126.06 mm |
| Cash burn (monthly) | (no burn) | 15.84 mm | 40.67 mm | 32.05 mm | 40.53 mm | 30.65 mm |
| Cash used (since last report) | n/a | 32.95 mm | 84.59 mm | 66.68 mm | 84.30 mm | 63.76 mm |
| Cash remaining | n/a | 93.11 mm | 41.47 mm | 59.38 mm | 41.76 mm | 62.30 mm |
| Runway (months of cash) | n/a | 5.9 | 1.0 | 1.9 | 1.0 | 2.0 |
| 13F holders | Current |
|---|---|
| Total holders | 159 |
| Opened positions | 32 |
| Closed positions | 21 |
| Increased positions | 73 |
| Reduced positions | 37 |
| 13F shares | Current |
|---|---|
| Total value | 938.06 bn |
| Total shares | 127.64 mm |
| Total puts | 978.50 k |
| Total calls | 78.70 k |
| Total put/call ratio | 12.4 |
| Largest owners | Shares | Value |
|---|---|---|
| JHG Janus Henderson | 16.51 mm | $129.18 bn |
| Ra Capital Management | 14.18 mm | $110.85 bn |
| Suvretta Capital Management | 10.20 mm | $79.79 bn |
| BlackRock | 7.89 mm | $61.70 bn |
| RTW Investments | 7.48 mm | $58.48 bn |
| Deep Track Capital | 6.48 mm | $50.66 bn |
| Vanguard | 5.69 mm | $44.51 bn |
| Citadel Advisors | 4.73 mm | $36.99 bn |
| Biotechnology Value Fund L P | 4.33 mm | $41.78 mm |
| BVF | 4.33 mm | $33.89 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 17 Feb 25 | Rohan Palekar | Common Stock | Payment of exercise | Dispose F | No | No | 10.57 | 3,249 | 34.34 k | 862,240 |
| 17 Feb 25 | Ryan Martins | Common Stock | Payment of exercise | Dispose F | No | No | 10.57 | 780 | 8.24 k | 269,674 |
| 17 Feb 25 | Harry H Mansbach | Common Stock | Payment of exercise | Dispose F | No | No | 10.57 | 1,050 | 11.10 k | 318,834 |
| 9 Feb 25 | Rohan Palekar | Common Stock | Payment of exercise | Dispose F | No | No | 11.41 | 8,946 | 102.07 k | 864,692 |
| 9 Feb 25 | Ryan Martins | Common Stock | Payment of exercise | Dispose F | No | No | 11.41 | 3,828 | 43.68 k | 270,454 |
